Overview

Curcumin in Combination With 5FU for Colon Cancer

Status:
Active, not recruiting
Trial end date:
2020-06-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and find the response rate of combining the dietary supplement, curcumin, with the standard of care, FDA-approved chemotherapy drug 5-fluorouracil (5FU, Adracil) and see what effects (good and bad) that the combined treatments have on colon cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
Baylor Research Institute
Treatments:
Curcumin
Fluorouracil